Serum Vitamin D levels in pediatric patients and its association with COVID-19 clinical manifestation: A meta-analysis and systematic review

Andrew  Jonatan; Retno Asih  Setyoningrum

doi:10.30574/gscbps.2021.17.2.0328

Authors

Andrew Jonatan Indrapura Field Hospital, Surabaya, Indonesia ATTN: Andrew Jonatan Indrapura ST No. 17., Surabaya, Indonesia.
Retno Asih Setyoningrum Departement of Pediatrics, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.

DOI:

https://doi.org/10.30574/gscbps.2021.17.2.0328

Keywords:

Children, COVID-19, Pediatric Patients, Vitamin D

Abstract

Background: Vitamin D is involved in human immune system homeostasis and thought to be beneficial for COVID-19 patients, including pediatric population. However, there is still a paucity of information on association of serum vitamin D levels and COVID-19 clinical manifestation in pediatric patients. This study evaluated the association between serum vitamin D levels and clinical manifestations of COVID-19 in pediatric patients.

Methods: We searched PubMed and Google Scholar for articles reporting association between vitamin D and COVID-19 clinical manifestations in pediatric patients. We searched for English-written articles only. PRISMA-MOOSE guideline and quality checklist was complied and statistical analysis was performed using RevMan 5.4.

Results: Ten studies with total of 1,225 patients reported were reviewed. Low vitamin D levels was significantly associated with higher incidence of severe COVID-19 with pooled OR was 5.57 (1.59-19.55; p=0.007). Clinical symptoms were compared between low and normal vitamin D levels. Incidence of fever, cough, ageusia, anosmia, headache, and fatigue were not significantly different between group, with pooled RR was 2.13 (0.13-33.73; p=0.59), 1.25 (0.25-6.22; p=0.78), 0.47 (0.05-4.76; p=0.52), 1.25 (0.21-7.41; p=0.81), 0.91 (0.33-2.55; p=0.86), and 1.02 (0.47-2.22; p=0.96), respectively. The mean count of leukocytes and lymphocytes in the two groups were also not significantly different with pooled RR was -0.49 (-1.39-0.41; p=0.28), and -0.73 (-1.65-0.20; p=0.12), respectively.

Conclusion: Low serum vitamin D level (<20 ng/ml) is associated with the severity of COVID-19 in pediatric patients, but do not affect symptoms and laboratory parameters. Vitamin D supplementation might be beneficial for children undergo medical quarantine and isolation.

Metrics

Metrics Loading ...

References

Wang F, Lancet CZ.-T. U. What to do next to control the 2019-nCoV epidemic? thelancet.com. 2020.

Mosleh W, Chen K, Pfau SE, Vashist A. Endotheliitis and endothelial dysfunction in patients with COVID-19: its role in thrombosis and adverse outcomes. 2020.

Amdal, C. D. et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual. Life Res. 2021; 1–15.

Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. Lancet. 2020; 395: 945–947.

Nowson C. A. et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med. J. Aust. 2012; 196: 686–687.

Yu L. et al. Effect of pandemic-related confinement on vitamin D status among children aged 0--6 years in Guangzhou, China: a cross-sectional study. Risk Manag. Healthc. Policy. 2020; 13: 2669.

Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 2008; 88: 491S--499S.

Lips P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006; 92: 4–8.

Wang Z. et al. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis. Clin. Endocrinol. (Oxf). 2021.

Yousfi, N., Bragazzi, N. L., Briki, W., Zmijewski, P. & Chamari, K. The COVID-19 pandemic: how to maintain a healthy immune system during the lockdown--a multidisciplinary approach with special focus on athletes. Biol. Sport. 2020; 37: 211.

Rustecka, A. et al. The Impact of COVID-19 Pandemic during 2020--2021 on the Vitamin D Serum Levels in the Paediatric Population in Warsaw, Poland. Nutrients. 2021; 13: 1990.

Wagner CL, Greer FR, others. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008; 122: 1142–1152.

Nowson CA, Margerison C. Vitamin D intake and vitamin D status of Australians. Med. J. Aust. 2002; 177: 149–152.

Shah K, Varna VP, Pandya A, Saxena D. Low vitamin D levels and prognosis in a COVID-19 pediatric population: a systematic review. QJM An Int. J. Med. 2021.

Weir EK, Thenappan T, Bhargava M, Chen Y, Does vitamin D deficiency increase the severity of COVID-19? Clin. Med. (Northfield. Il). 2020; 20: e107.

Shah K, Saxena D, Mavalankar D. Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM An Int. J. Med. 2021; 114: 175–181.

Darren A. et al. Vitamin D status of children with Paediatric Inflammatory Multisystem Syndrome Temporally associated with Severe acute respiratory syndrome coronavirus 2 (PIMS-TS). Br. J. Nutr. 2021; 1–26.

Molla GK, Uzun ÖÜ, Koç N, Yecsil, B. Ö. & Bayhan, G. . I. Evaluation of nutritional status in pediatric patients diagnosed with Covid-19 infection. Clin. Nutr. ESPEN. 2021.

Fekete T. In adults and children in the ED with COVID-19 symptoms or a confirmed contact, a rapid POC antigen test had≥ 72% sensitivity and≥ 99% specificity vs. RT-PCR. Ann. Intern. Med. 2021; 174: JC83.

Isoldi S. et al. The comprehensive clinic, laboratory, and instrumental evaluation of children with COVID-19: A 6-months prospective study. J. Med. Virol. 2021; 93: 3122–3132.

Yilmaz, K. & cSen, V. Is vitamin D deficiency a risk factor for COVID-19 in children? Pediatr. Pulmonol. 2020; 55: 3595–3601.

Bayramouglu, E. et al. The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital. Eur. J. Pediatr. 2021; 1–7.

Alpcan A, Tursun S, Kandur Y. Vitamin D levels in children with COVID-19: a report from Turkey. Epidemiol. & Infect. 2021; 149.

Söbü E, Karaaslan A, Çetin C, Akin, Y. Vitamin D levels of COVID-19 positive sypmtomatic pediatric cases. 2021.

Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with vitamin D deficiency. Nutrition. 2021; 84, 111106.

Mok CK. et al. Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis. BioRxiv. 2020.

Biesalski, H. K. Vitamin D deficiency and co-morbidities in COVID-19 patients--A fatal relationship? Nfs J. 2020; 20: 10.

Jolliffe DA. et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes & Endocrinol. 2021.

Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004; 80: 1678S--1688S.

Asyary A, Veruswati M. Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia. Sci. Total Environ. 2020; 729: 139016.

Taha, R. et al. The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes? Int. J. Gen. Med. 2021; 14: 3849.

Holick MF. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. & Metab. 2011; 96: 1911–1930.

Zhu, J. & DeLuca, H. F. Vitamin D 25-hydroxylase--four decades of searching, are we there yet? Arch. Biochem. Biophys. 2012; 523: 30–36.

Zhu JG, Ochalek JT, Kaufmann M, Jones G, DeLuca HF. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc. Natl. Acad. Sci. 2013; 110: 15650–15655.

Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the liver—correlation or cause? Nutrients. 2018; 10: 496.

Panfili FM. et al. Possible role of vitamin D in Covid-19 infection in pediatric population. J. Endocrinol. Invest. 2021; 44: 27–35.

Kalia V, Studzinski GP, Sarkar S. Role of vitamin D in regulating COVID-19 severity—An immunological perspective. J. Leukoc. Biol. 2021.

Zdrenghea, M. T. et al. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev. Med. Virol. 2017; 27: e1909.

Strollo R, Pozzilli P. DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? Diabetes. Metab. Res. Rev. 2020; 36: e3330.

Zheng M. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. & Mol. Immunol. 2020; 55: 102763.

Liu J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020; 55: 102763.